In the News September 10, 2019

Law360 | FDA Faces Free Speech Issues with Juul Warnings

Marc Scheineson comments on First Amendment issues surrounding the U.S. Food and Drug Administration’s crackdown on advertising by e-cigarette maker Juul.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.